4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

Date: July 5, 2016
Pages: 54
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: 4FF8D61A4D9EN
Leaflet:

Download PDF Leaflet

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review
4SC AG (VSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

4SC AG (4SC) discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at various stages of clinical development and early-stage research projects. The company’s research programs are related to cancer stem cells, ion channel blockers and cytokine modulation. It develops and markets products through partnerships with pharmaceutical and biotech companies. 4SC research focuses treatment of cancer and autoimmune diseases. It operates through its subsidiary 4SC Discovery GmbH. 4SC is headquartered in Martinsried, Germany.

4SC AG Key Recent Developments

May 12, 2016: 4SC reports on key events in Q1 2016
Mar 30, 2016: 4SC announces results for financial year 2015
Nov 11, 2015: 4SC announces financial results for the first nine months and the third quarter of 2015
Aug 06, 2015: 4SC announces financial results for the first half of 2015
May 07, 2015: 4SC Announces Financial Results for the First Quarter of 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

&%$#@ abc 4SC AG - KEY FACTS
&%$#@ abc 4SC AG - KEY EMPLOYEES
&%$#@ abc 4SC AG - KEY EMPLOYEE BIOGRAPHIES
&%$#@ abc 4SC AG - MAJOR PRODUCTS AND SERVICES
&%$#@ abc 4SC AG - PHARMACEUTICAL PIPELINE PRODUCTS DATA
&%$#@ abc 4SC AG, PIPELINE PRODUCTS BY THERAPY AREA
&%$#@ abc 4SC AG, PIPELINE PRODUCTS BY DEVELOPMENT PHASE
&%$#@ abc 4SC AG - HISTORY
&%$#@ abc 4SC AG - COMPANY STATEMENT
&%$#@ abc 4SC AG - LOCATIONS AND SUBSIDIARIES
Head Office

SECTION 2 – COMPANY ANALYSIS

&%$#@ abc 4SC AG - BUSINESS DESCRIPTION
&%$#@ abc 4SC AG - CORPORATE STRATEGY
&%$#@ abc 4SC AG - SWOT ANALYSIS
SWOT Analysis - Overview
&%$#@ abc 4SC AG - STRENGTHS
Strength - 4SCan Technology
Strength - 4SC Discovery GmbH
Strength - Research and Development Activities
&%$#@ abc 4SC AG - WEAKNESSES
Weakness - History of Losses
Weakness - Competitive Positioning
&%$#@ abc 4SC AG - OPPORTUNITIES
Opportunity - Growth in Health Care Industry
Opportunity - Product Pipeline
Opportunity - Major Collaboration with Yakult
&%$#@ abc 4SC AG - THREATS
Threat - Growing Parallel Trade
Threat - Competitive Pressures
Threat - Technological Changes
&%$#@ abc 4SC AG - KEY COMPETITORS

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

&%$#@ abc 4SC AG, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2010 TO YTD 2016
&%$#@ abc 4SC AG, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2010 TO YTD 2016
&%$#@ abc 4SC AG, RECENT DEALS SUMMARY

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 12, 2016: 4SC reports on key events in Q1 2016
Mar 30, 2016: 4SC announces results for financial year 2015
Nov 11, 2015: 4SC announces financial results for the first nine months and the third quarter of 2015
Aug 06, 2015: 4SC announces financial results for the first half of 2015
May 07, 2015: 4SC Announces Financial Results for the First Quarter of 2015
Apr 01, 2015: Dr Susanne Danhauser-Riedl joins 4SC as Chief Medical Officer to strengthen management and clinical development team
Mar 25, 2015: 4SC publishes results for financial year 2014
Jan 12, 2015: Prof. Dr. Helga Rübsamen-Schaeff and Joerg von Petrikowsky join the Supervisory Board of 4SC

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

&%$#@ abc 4SC AG, KEY FACTS
&%$#@ abc 4SC AG, KEY EMPLOYEES
&%$#@ abc 4SC AG, KEY EMPLOYEE BIOGRAPHIES
&%$#@ abc 4SC AG, MAJOR PRODUCTS AND SERVICES
&%$#@ abc 4SC AG, NUMBER OF PIPELINE PRODUCTS BY THERAPY AREA
&%$#@ abc 4SC AG, NUMBER OF PIPELINE PRODUCTS BY DEVELOPMENT STAGE
&%$#@ abc 4SC AG, PIPELINE PRODUCTS BY THERAPY AREA AND DEVELOPMENT PHASE
&%$#@ abc 4SC AG, HISTORY
&%$#@ abc 4SC AG, KEY COMPETITORS
&%$#@ abc 4SC AG, RATIOS BASED ON CURRENT SHARE PRICE
&%$#@ abc 4SC AG, ANNUAL RATIOS
&%$#@ abc 4SC AG, INTERIM RATIOS
&%$#@ abc 4SC AG, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2010 TO YTD 2016
&%$#@ abc 4SC AG, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2010 TO YTD 2016
&%$#@ abc 4SC AG, RECENT DEALS SUMMARY
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

&%$#@ abc 4SC AG, PIPELINE PRODUCTS BY THERAPY AREA
&%$#@ abc 4SC AG, PIPELINE PRODUCTS BY DEVELOPMENT PHASE
&%$#@ abc 4SC AG, PERFORMANCE CHART (2011 - 2015)
&%$#@ abc 4SC AG, RATIO CHARTS
&%$#@ abc 4SC AG, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2010 TO YTD 2016
&%$#@ abc 4SC AG, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2010 TO YTD 2016
Skip to top


Ask Your Question

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: